• English
  • 简体中文
Login Register
Current Location: Home > Marketing Drugs(EU) Feedback Help
EMA Approvals
-
HMA Approvals
-

EMA:Drugs approved by European Medicines Agency through centralized Procedure. 

HMA:Drugs approved by EU members through Mutual Recognition Procedure.

For more information check in official website of members:

Drug label information in UK

Public Assessment Reports in UK

Marketed drugs in France

Marketed drugs in Italy

Marketed drugs in Switzerland

Marketed drugs in Sweden

Marketed drugs in Germany

Click here for more information

Brand name Nonproprietary Name Authorization date Marketing authorisation holder
GONAL-f follitropin alfa 1995-10-20 Merck Europe B.V.
Taxotere docetaxel 1995-11-27 Sanofi Mature IP
Betaferon interferon beta-1b 1995-11-30 Bayer AG?
CellCept mycophenolate mofetil 1996-02-14 Roche Registration GmbH
Fareston toremifene 1996-02-14 Orion Corporation
NovoSeven eptacog alfa (activated) 1996-02-23 Novo Nordisk A/S
Humalog insulin lispro 1996-04-30 Eli Lilly Nederland B.V.
Puregon follitropin beta 1996-05-02 N.V. Organon
Zerit stavudine 1996-05-08 Bristol-Myers Squibb Pharma EEIG
Rilutek riluzole 1996-06-10 Sanofi Mature IP
Caelyx pegylated liposomal doxorubicin 1996-06-20 Baxter Holding B.V.
Bondronat ibandronic acid 1996-06-25 Atnahs Pharma Netherlands B.V.
Destara ibandronic acid 1996-06-25 Roche Registration Ltd.
Tritanrix HepB diphtheria (D), tetanus (T), pertussis (whole cell) (Pw) and hepatitis B (rDNA) (HBV) vaccine (adsorbed) 1996-07-19 GlaxoSmithKline Biologicals S.A.
Epivir lamivudine 1996-08-08 ViiV Healthcare BV
Norvir ritonavir 1996-08-25 AbbVie Deutschland GmbH Co. KG
Rapilysin reteplase 1996-08-29 Actavis Group PTC ehf
Ecokinase reteplase 1996-08-29 Roche Registration Ltd.
Tecnemab K1 anti-melanoma mab fragments 1996-09-05 Amersham Sorin.S.r.l.
Twinrix Adult hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed) 1996-09-19 GlaxoSmithKline Biologicals S.A.